Skip to content
10-Q

Quarterly Report

BIOETHICS, LTD.

0001096906-23-002192

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 14, 2023 1.14M sh
Cash And Equivalents Q3 2023 · Sep 30, 2023 $483
Cash And Equivalents Q3 2023 · Dec 31, 2022 $295
Current Liabilities Q3 2023 · Sep 30, 2023 $752.35K
Current Liabilities Q3 2023 · Dec 31, 2022 $679.41K
Total Liabilities Q3 2023 · Sep 30, 2023 $752.35K
Total Liabilities Q3 2023 · Dec 31, 2022 $679.41K
Current Assets Q3 2023 · Sep 30, 2023 $483
Current Assets Q3 2023 · Dec 31, 2022 $295
Total Assets Q3 2023 · Sep 30, 2023 $483
Total Assets Q3 2023 · Dec 31, 2022 $295
Eps Basic Q3 2023 · Sep 30, 2023 −$0.02
Eps Basic Q3 2023 · Sep 30, 2023 −$0.06
Eps Basic Q3 2023 · Sep 30, 2022 −$0.02
Eps Basic Q3 2023 · Sep 30, 2022 −$0.06
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$22.33K
Stockholders Equity Q3 2023 · Sep 30, 2022 −$658.42K
Stockholders Equity Q3 2023 · Jun 30, 2022 −$636.21K
Stockholders Equity Q3 2023 · Mar 31, 2022 −$607.59K
Stockholders Equity Q3 2023 · Dec 31, 2021 −$585.91K
Sga Expense Q3 2023 · Sep 30, 2022 $10.5K
Sga Expense Q3 2023 · Sep 30, 2022 $38.41K
Operating Income Q3 2023 · Sep 30, 2022 −$10.5K
Operating Income Q3 2023 · Sep 30, 2022 −$38.41K
Revenue Q3 2023 · Sep 30, 2022 $0
Revenue Q3 2023 · Sep 30, 2022 $0